Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18209
Country/Region: Kenya
Year: 2017
Main Partner: Liverpool VCT, Care and Treatment
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $5,626,931 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Orphans and Vulnerable Children (HKID) $702,340
Care: Pediatric Care and Support (PDCS) $0
Testing: HIV Testing and Counseling (HVCT) $224,128
Sexual Prevention: Other Sexual Prevention (HVOP) $4,548,014
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $152,449
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2018 1,698
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2018 321
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2018 1,416
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2018 624
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2018 68
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2018 31
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2018 3,448
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2018 1,585
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2018 344
GEND_GBV 20-24, Male, Sexual Violence (Post-Rape Care) 2018 126
GEND_GBV 25-49, Female, Physical and/or Emotional Violence 2018 4,545
GEND_GBV 25-49, Female, Sexual Violence (Post-Rape Care) 2018 1,091
GEND_GBV 25-49, Male, Physical and/or Emotional Violence 2018 219
GEND_GBV 25-49, Male, Sexual Violence (Post-Rape Care) 2018 105
GEND_GBV 50+, Female, Physical and/or Emotional Violence 2018 89
GEND_GBV 50+, Female, Sexual Violence (Post-Rape Care) 2018 52
GEND_GBV 50+, Male, Physical and/or Emotional Violence 2018 16
GEND_GBV 50+, Male, Sexual Violence (Post-Rape Care) 2018 8
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 1,578
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 11,843
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 3,943
GEND_GBV Number of people receiving post-GBV care 2018 15,786
HTS_TST By Key Population: FSW, Negative 2018 4,534
HTS_TST By Key Population: MSM, Negative 2018 2,346
HTS_TST By Key Population: PWID, Negative 2018 63
HTS_TST By Key Population: TG, Negative 2018 8
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 33,136
HTS_TST Service Delivery Point (Community) Index Mod: <1, Negative 2018 2
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2018 3
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2018 15
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2018 24
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2018 30
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Female, Negative 2018 54
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Male, Negative 2018 54
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2018 2
HTS_TST Service Delivery Point (Community) Mobile Testing: <1, Negative 2018 29
HTS_TST Service Delivery Point (Community) Mobile Testing: 1-9, Negative 2018 31
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Female, Negative 2018 56
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Male, Negative 2018 56
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2018 708
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2018 532
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2018 1,457
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2018 857
HTS_TST Service Delivery Point (Community) Mobile Testing: 25-49, Female, Negative 2018 1,117
HTS_TST Service Delivery Point (Community) Mobile Testing: 25-49, Male, Negative 2018 816
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2018 29
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2018 29
HTS_TST Service Delivery Point (Community) VCT Mod: <1, Negative 2018 1
HTS_TST Service Delivery Point (Community) VCT Mod: 1-9, Negative 2018 2
HTS_TST Service Delivery Point (Community) VCT Mod: 10-14, Female, Negative 2018 1
HTS_TST Service Delivery Point (Community) VCT Mod: 10-14, Male, Negative 2018 1
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Female, Negative 2018 18
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Male, Negative 2018 13
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Female, Negative 2018 36
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Male, Negative 2018 21
HTS_TST Service Delivery Point (Community) VCT Mod: 25-49, Female, Negative 2018 27
HTS_TST Service Delivery Point (Community) VCT Mod: 25-49, Male, Negative 2018 20
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Female, Negative 2018 1
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Male, Negative 2018 1
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2018 20
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 8
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 48
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 33
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 214
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 221
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 508
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 472
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 20
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 24
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2018 101
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2018 118
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2018 264
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2018 264
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 3,125
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 2,346
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 6,183
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 3,638
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 4,510
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 3,230
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 98
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 94
HTS_TST Sum of Test Result disaggregates 2018 1,094
HTS_TST_POS By Key Population: FSW, Positive 2018 111
HTS_TST_POS By Key Population: MSM, Positive 2018 74
HTS_TST_POS By Key Population: PWID, Positive 2018 2
HTS_TST_POS By Key Population: TG, Positive 2018 2
HTS_TST_POS By Test Result: Positive 2018 1,094
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Female, Positive 2018 18
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Male, Positive 2018 12
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: <1, Positive 2018 2
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 1-9, Positive 2018 2
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 10-14, Female, Positive 2018 5
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 10-14, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2018 62
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2018 46
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2018 133
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2018 80
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 25-49, Female, Positive 2018 110
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 25-49, Male, Positive 2018 78
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 25-49, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 25-49, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 12
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 52
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 56
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 130
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 117
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) VCT: <1, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 16
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2018 17
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 77
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 85
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 190
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 177
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 8
KP_MAT Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months 2018 636
KP_MAT Sex: Female 2018 191
KP_MAT Sex: Male 2018 445
KP_MAT Sum of Sex disaggregates 2018 636
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 9,947
KP_PREV By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 215
KP_PREV By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 501
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 3,558
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 340
KP_PREV By key population type: Transgender who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 10
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 14,571
OVC_SERV Age/Sex: 10-14 Female 2018 2,893
OVC_SERV Age/Sex: 15-17 Female 2018 4,765
OVC_SERV By: Age/sex: 18-24 Female 2018 4,905
OVC_SERV By: Age/sex: 25+ Female 2018 843
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2018 13,406
OVC_SERV Program Completion: Active 2018 13,060
OVC_SERV Program Completion: Exited without graduation 2018 211
OVC_SERV Program Completion: Transferred 2018 135
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 10-14 2018 49
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 15-17 2018 592
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 18-24 2018 2,193
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 25+ 2018 172
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 10-14 2018 401
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 15-17 2018 2,927
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 18-24 2018 1,126
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 25+ 2018 53
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 10-14 2018 3,216
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 15-17 2018 5,334
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 18-24 2018 5,632
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 25+ 2018 843
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 10-14 2018 3,003
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 15-17 2018 532
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 18-24 2018 1,513
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 25+ 2018 127
OVC_SERV Sum of Age/Sex disaggregates 2018 7,658
PP_PREV Age/sex: 10-14 Female 2018 8,146
PP_PREV Age/sex: 10-14 Male 2018 6,313
PP_PREV Age/sex: 15-19 Female 2018 12,647
PP_PREV Age/sex: 15-19 Male 2018 6,313
PP_PREV Age/sex: 20-24 Female 2018 13,872
PP_PREV Age/sex: 20-24 Male 2018 6,313
PP_PREV Age/sex: 25-49 Female 2018 4,213
PP_PREV Age/sex: 25-49 Male 2018 6,313
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 64,130
PP_PREV Sum of Age/Sex disaggregates 2018 64,130
PrEP_NEW Female 15-19 2018 111
PrEP_NEW Female 20-24 2018 291
PrEP_NEW Female 25-49 2018 35
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2018 437
TB_PREV By Age/Sex (Numerator): <15, Female 2018 10
TB_PREV By Age/Sex (Numerator): <15, Male 2018 7
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 711
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 298
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 1,026
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 1,026
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 1,140
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 19
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 11
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 793
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 317
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 1,140
TX_CURR Age/Sex: <1-9 2018 26
TX_CURR Age/Sex: 10-14 Female 2018 42
TX_CURR Age/Sex: 10-14 Male 2018 30
TX_CURR Age/Sex: 15-19 Female 2018 254
TX_CURR Age/Sex: 15-19 Male 2018 160
TX_CURR Age/Sex: 20-24 Female 2018 510
TX_CURR Age/Sex: 20-24 Male 2018 366
TX_CURR Age/Sex: 25-49 Female 2018 2,004
TX_CURR Age/Sex: 25-49 Male 2018 1,333
TX_CURR Age/Sex: 50+ Female 2018 108
TX_CURR Age/Sex: 50+ Male 2018 211
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 5,044
TX_CURR Sum of age/sex disaggregates 2018 414
TX_NEW By Age/Sex: 10-14 Female 2018 19
TX_NEW By Age/Sex: 10-14 Male 2018 11
TX_NEW By Age/Sex: 15-19 Female 2018 92
TX_NEW By Age/Sex: 15-19 Male 2018 43
TX_NEW By Age/Sex: 20-24 Female 2018 283
TX_NEW By Age/Sex: 20-24 Male 2018 110
TX_NEW By Age/Sex: 25-49 Female 2018 375
TX_NEW By Age/Sex: 25-49 Male 2018 138
TX_NEW By Age/Sex: 50+ Female 2018 43
TX_NEW By Age/Sex: 50+ Male 2018 26
TX_NEW By Key populations: People who inject drugs (PWID) 2018 55
TX_NEW FSW 2018 230
TX_NEW MSM 2018 83
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 1,140
TX_NEW Sum of Age/Sex disaggregates 2018 1,140
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 5,044
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 4,539
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 57
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 4
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 25
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 2
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 2,408
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 180
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 1,731
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 132
TX_PVLS Numerator: Indication: Routine 2018 4,221
TX_PVLS Numerator: Indication: Targeted 2018 318
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 62
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 5
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 28
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 2
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 2,678
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 200
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 1,923
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 146
TX_PVLS_den Denominator: Indication: Routine 2018 4,691
TX_PVLS_den Denominator: Indication: Targeted 2018 353
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 19
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 11
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 752
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 301
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 1,083
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 1,140
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 19
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 11
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 793
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 317
Cross Cutting Budget Categories and Known Amounts Total: $1,400,000
Key Populations: MSM and TG $25,000
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Key Populations: Sex Workers $25,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Gender: Gender Based Violence (GBV) $50,000
GBV Prevention
Implementation
Capacity building
Gender: Gender Equality $50,000
Equity in HIV prevention, care, treatment and support
Implementation
Capacity building
Human Resources for Health $1,250,000